NASDAQ:BCPCBalchem Stock Price, Forecast & News

Balchem's stock was trading at $89.29 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BCPC shares have increased by 12.3% and is now trading at $100.26.
View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Balchem.

Balchem is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Balchem.

Balchem Co. (NASDAQ:BCPC) released its quarterly earnings data on Friday, July, 31st. The basic materials company reported $0.85 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.55 by $0.30. The basic materials company earned $173.36 million during the quarter, compared to analyst estimates of $161.35 million. Balchem had a return on equity of 14.32% and a net margin of 12.18%. The business's revenue was up 7.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.77 EPS.
View Balchem's earnings history.

Balchem declared an annual dividend on Wednesday, December 18th. Shareholders of record on Monday, December 30th will be paid a dividend of $0.52 per share on Friday, January 17th. This represents a yield of 0.51%. The ex-dividend date is Friday, December 27th. This is a boost from Balchem's previous annual dividend of $0.47.
View Balchem's dividend history.

2 analysts have issued 1 year target prices for Balchem's shares. Their forecasts range from $100.00 to $104.00. On average, they expect Balchem's stock price to reach $102.00 in the next year. This suggests a possible upside of 1.7% from the stock's current price.
View analysts' price targets for Balchem.

Media headlines about BCPC stock have been trending negative this week, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Balchem earned a news impact score of -2.2 on InfoTrie's scale. They also gave news articles about the basic materials company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days.
View the latest news about Balchem.

Balchem saw a drop in short interest in the month of July. As of July 15th, there was short interest totaling 433,300 shares, a drop of 12.4% from the June 30th total of 494,500 shares. Based on an average trading volume of 167,300 shares, the days-to-cover ratio is presently 2.6 days. Approximately 1.4% of the shares of the stock are sold short.
View Balchem's Current Options Chain.

Some companies that are related to Balchem include Sherwin-Williams (SHW), Ecolab (ECL), International Flavors & Fragrances (IFF), Celanese (CE), RPM International (RPM), Albemarle (ALB), Ashland Global (ASH), NewMarket (NEU), Quaker Chemical (KWR), W. R. Grace & Co (GRA), Stepan (SCL), HB Fuller (FUL), Sensient Technologies (SXT), PolyOne (POL) and Innospec (IOSP).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Gilead Sciences (GILD), AbbVie (ABBV), CVS Health (CVS), Ecolab (ECL), Adobe (ADBE), Mastercard (MA), Altria Group (MO), NVIDIA (NVDA), Pfizer (PFE) and Starbucks (SBUX).

Balchem trades on the NASDAQ under the ticker symbol "BCPC."

Balchem's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Tributary Capital Management LLC (0.68%), Assenagon Asset Management S.A. (0.40%), Scout Investments Inc. (0.25%), Comerica Bank (0.21%), New York State Teachers Retirement System (0.20%) and Bath Savings Trust Co (0.16%). Company insiders that own Balchem stock include Daniel E Knutson, David F Ludwig and Scott C Mason.
View institutional ownership trends for Balchem.

BCPC stock was sold by a variety of institutional investors in the last quarter, including Moody Aldrich Partners LLC, SG Americas Securities LLC, Brinker Capital Inc., Bath Savings Trust Co, Wendell David Associates Inc., Strs Ohio, Envestnet Asset Management Inc., and New York State Teachers Retirement System.
View insider buying and selling activity for Balchem.

BCPC stock was acquired by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., First Trust Advisors LP, Tributary Capital Management LLC, Raymond James & Associates, Exchange Traded Concepts LLC, Zurcher Kantonalbank Zurich Cantonalbank , Cambridge Investment Research Advisors Inc., and State of Alaska Department of Revenue. Company insiders that have bought Balchem stock in the last two years include Daniel E Knutson, and Scott C Mason.
View insider buying and selling activity for Balchem.

Shares of BCPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BCPC stock can currently be purchased for approximately $100.26.

Balchem has a market capitalization of $3.24 billion and generates $643.71 million in revenue each year. The basic materials company earns $79.67 million in net income (profit) each year or $3.19 on an earnings per share basis. Balchem employs 1,424 workers across the globe.

The official website for Balchem is www.balchem.com.

Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The basic materials company can be reached via phone at 845-326-5600 or via email at [email protected]